LRMR - Financial Reports List - Larimar Therapeutics, Inc. - IntrinsicAlpha

Larimar Therapeutics, Inc. LRMR

Healthcare - Biotechnology - NASDAQ - US

$ 2.38

5.24 %

$ 152 M

Market Cap

-1.52

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	0.00%	-121.84%	-120.96%
Annual Report	FY	10-K	2024-12-31	0.00%	-118.15%	-117.66%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	-71.00%	-76.65%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	-158.51%	-155.71%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	-170.62%	-119.12%
Quarterly Report	Q4	8-K	2023-12-31	0.00%	-54.48%	-35.66%
Annual Report	FY	10-K	2023-12-31	0.00%	-8.09%	-14.32%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	-11.53%	-21.45%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	3.25%	-10.74%
Quarterly Report	Q1	8-K	2023-03-31	0.00%	39.83%	14.07%

1